Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avet-Loiseau

Showing results (21-30 of 381) with videos related to

Pageof 39
Sort By:
Blood|July 29, 2021
Requirements for operational cure in multiple myelomaMohamad Mohty, Hervé Avet-Loiseau, Jean-Luc Harousseau
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Gene Expression Profiles in Myeloma: Ready for the Real World?Raphael Szalat, Herve Avet-Loiseau, Nikhil C Munshi
Blood|October 7, 2020
Risk factors in multiple myeloma: is it time for a revision?Jill Corre, Nikhil C Munshi, Hervé Avet-Loiseau
Journal of Pediatric Hematology/Oncology|February 1, 1995
Clonal hematologic disorders in Down syndrome. A reviewH Avet-Loiseau, F Mechinaud, J L Harousseau
Blood|July 30, 2009
The role of complete response in multiple myelomaJean-Luc Harousseau, Michel Attal, Herve Avet-Loiseau
Blood|May 13, 2022
MRD in multiple myeloma: does CR really matter?Bruno Paiva, Jesus San-Miguel, Hervé Avet-Loiseau
La Revue De Medecine Interne|June 15, 2007
[Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival]O Decaux, L Lodé, S Minvielle, et al.
Archives Francaises De Pediatrie|March 1, 1992
[Ataxia telangiectasia]H Avet-Loiseau, F Mechinaud-Lacroix, J L Harousseau
Oncotarget|January 5, 2018
Optimizing therapy for del(17p) multiple myelomaHervé Avet-Loiseau, Paul G Richardson, Alessandra di Bacco
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapiesPhilippe Moreau, Hervé Avet-Loiseau, Jean-Luc Harousseau, et al.
Pageof 39

Showing results (21-30 of 381) with videos related to

Sort By:
Pageof 39
Blood|July 29, 2021
Requirements for operational cure in multiple myelomaMohamad Mohty, Hervé Avet-Loiseau, Jean-Luc Harousseau
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Gene Expression Profiles in Myeloma: Ready for the Real World?Raphael Szalat, Herve Avet-Loiseau, Nikhil C Munshi
Blood|October 7, 2020
Risk factors in multiple myeloma: is it time for a revision?Jill Corre, Nikhil C Munshi, Hervé Avet-Loiseau
Journal of Pediatric Hematology/Oncology|February 1, 1995
Clonal hematologic disorders in Down syndrome. A reviewH Avet-Loiseau, F Mechinaud, J L Harousseau
Blood|July 30, 2009
The role of complete response in multiple myelomaJean-Luc Harousseau, Michel Attal, Herve Avet-Loiseau
Blood|May 13, 2022
MRD in multiple myeloma: does CR really matter?Bruno Paiva, Jesus San-Miguel, Hervé Avet-Loiseau
La Revue De Medecine Interne|June 15, 2007
[Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival]O Decaux, L Lodé, S Minvielle, et al.
Archives Francaises De Pediatrie|March 1, 1992
[Ataxia telangiectasia]H Avet-Loiseau, F Mechinaud-Lacroix, J L Harousseau
Oncotarget|January 5, 2018
Optimizing therapy for del(17p) multiple myelomaHervé Avet-Loiseau, Paul G Richardson, Alessandra di Bacco
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapiesPhilippe Moreau, Hervé Avet-Loiseau, Jean-Luc Harousseau, et al.
Pageof 39